The global market for Ultrasound-Responsive Drug Delivery Systems was valued at US$ 620 million in the year 2024 and is projected to reach a revised size of US$ 1167 million by 2031, growing at a CAGR of 9.4% during the forecast period.

Ultrasound-Responsive Drug Delivery Systems Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Ultrasound-Responsive Drug Delivery Systems competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

In 2024, global production of Ultrasound-Responsive Drug Delivery Systems reached approximately 12 million units, supported by a capacity of 15 million units. The average unit price was around USD 52, and manufacturers maintained a gross margin of about 46%. Ultrasound-Responsive Drug Delivery Systems are advanced therapeutic platforms that use external ultrasound waves to trigger or enhance the release of drugs at targeted sites within the body. These systems typically consist of carriers—such as liposomes, polymeric micelles, nanoparticles, or microbubbles—loaded with therapeutic agents and engineered to respond to ultrasound through mechanisms like cavitation, thermal effects, or mechanical disruption. The supply chain begins with upstream raw materials, including biodegradable polymers (e.g., PLGA), phospholipids, surfactants, and active pharmaceutical ingredients (APIs). Midstream manufacturing involves the formulation of drug–carrier complexes using techniques like emulsification, nanoprecipitation, or microfluidics, followed by ultrasonic response tuning and quality control. Downstream activities include sterilization, aseptic filling, packaging, and regulatory compliance for clinical applications. The final products are distributed to pharmaceutical companies, hospitals, and research institutions, where ultrasound equipment is used to localize and control drug release, enabling site-specific therapy with reduced systemic side effects.

North American market for Ultrasound-Responsive Drug Delivery Systems is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Ultrasound-Responsive Drug Delivery Systems is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Ultrasound-Responsive Drug Delivery Systems include OxSonics, Taiwan Liposome, PolyActiva, NanoCarrier, Celsion, Starpharma, InnoMedica, Insightec, CarThera, Nanobiotix, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ultrasound-Responsive Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ultrasound-Responsive Drug Delivery Systems.

The Ultrasound-Responsive Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ultrasound-Responsive Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ultrasound-Responsive Drug Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Ultrasound-Responsive Drug Delivery Systems Market Report

Report Metric	Details
Report Name	Ultrasound-Responsive Drug Delivery Systems Market
Accounted market size in year	US$ 620 million
Forecasted market size in 2031	US$ 1167 million
CAGR	9.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Microbubble-based Systems Nanobubble-based Systems
Segment by Application	Pharmaceutical Companies Healthcare Providers Contract Manufacturing Organizations Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	OxSonics, Taiwan Liposome, PolyActiva, NanoCarrier, Celsion, Starpharma, InnoMedica, Insightec, CarThera, Nanobiotix
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ultrasound-Responsive Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ultrasound-Responsive Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Ultrasound-Responsive Drug Delivery Systems Market growing?

Ans: The Ultrasound-Responsive Drug Delivery Systems Market witnessing a CAGR of 9.4% during the forecast period 2025-2031.

What is the Ultrasound-Responsive Drug Delivery Systems Market size in 2031?

Ans: The Ultrasound-Responsive Drug Delivery Systems Market size in 2031 will be US$ 1167 million.

Who are the main players in the Ultrasound-Responsive Drug Delivery Systems Market report?

Ans: The main players in the Ultrasound-Responsive Drug Delivery Systems Market are OxSonics, Taiwan Liposome, PolyActiva, NanoCarrier, Celsion, Starpharma, InnoMedica, Insightec, CarThera, Nanobiotix

What are the Application segmentation covered in the Ultrasound-Responsive Drug Delivery Systems Market report?

Ans: The Applications covered in the Ultrasound-Responsive Drug Delivery Systems Market report are Pharmaceutical Companies, Healthcare Providers, Contract Manufacturing Organizations, Others

What are the Type segmentation covered in the Ultrasound-Responsive Drug Delivery Systems Market report?

Ans: The Types covered in the Ultrasound-Responsive Drug Delivery Systems Market report are Microbubble-based Systems, Nanobubble-based Systems

1 Ultrasound-Responsive Drug Delivery Systems Market Overview

1.1 Product Definition

1.2 Ultrasound-Responsive Drug Delivery Systems by Type

1.2.1 Global Ultrasound-Responsive Drug Delivery Systems Market Value Comparison by Type (2024 VS 2031)

1.2.2 Microbubble-based Systems

1.2.3 Nanobubble-based Systems

1.3 Ultrasound-Responsive Drug Delivery Systems by Application

1.3.1 Global Ultrasound-Responsive Drug Delivery Systems Market Value by Application (2024 VS 2031)

1.3.2 Pharmaceutical Companies

1.3.3 Healthcare Providers

1.3.4 Contract Manufacturing Organizations

1.3.5 Others

1.4 Global Ultrasound-Responsive Drug Delivery Systems Market Size Estimates and Forecasts

1.4.1 Global Ultrasound-Responsive Drug Delivery Systems Revenue 2020-2031

1.4.2 Global Ultrasound-Responsive Drug Delivery Systems Sales 2020-2031

1.4.3 Global Ultrasound-Responsive Drug Delivery Systems Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Ultrasound-Responsive Drug Delivery Systems Market Competition by Manufacturers

2.1 Global Ultrasound-Responsive Drug Delivery Systems Sales Market Share by Manufacturers (2020-2025)

2.2 Global Ultrasound-Responsive Drug Delivery Systems Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Ultrasound-Responsive Drug Delivery Systems Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Ultrasound-Responsive Drug Delivery Systems, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Ultrasound-Responsive Drug Delivery Systems, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Ultrasound-Responsive Drug Delivery Systems, Product Type & Application

2.7 Global Key Manufacturers of Ultrasound-Responsive Drug Delivery Systems, Date of Enter into This Industry

2.8 Global Ultrasound-Responsive Drug Delivery Systems Market Competitive Situation and Trends

2.8.1 Global Ultrasound-Responsive Drug Delivery Systems Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Ultrasound-Responsive Drug Delivery Systems Players Market Share by Revenue

2.8.3 Global Ultrasound-Responsive Drug Delivery Systems Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Ultrasound-Responsive Drug Delivery Systems Market Scenario by Region

3.1 Global Ultrasound-Responsive Drug Delivery Systems Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Ultrasound-Responsive Drug Delivery Systems Sales by Region: 2020-2031

3.2.1 Global Ultrasound-Responsive Drug Delivery Systems Sales by Region: 2020-2025

3.2.2 Global Ultrasound-Responsive Drug Delivery Systems Sales by Region: 2026-2031

3.3 Global Ultrasound-Responsive Drug Delivery Systems Revenue by Region: 2020-2031

3.3.1 Global Ultrasound-Responsive Drug Delivery Systems Revenue by Region: 2020-2025

3.3.2 Global Ultrasound-Responsive Drug Delivery Systems Revenue by Region: 2026-2031

3.4 North America Ultrasound-Responsive Drug Delivery Systems Market Facts & Figures by Country

3.4.1 North America Ultrasound-Responsive Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Ultrasound-Responsive Drug Delivery Systems Sales by Country (2020-2031)

3.4.3 North America Ultrasound-Responsive Drug Delivery Systems Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Ultrasound-Responsive Drug Delivery Systems Market Facts & Figures by Country

3.5.1 Europe Ultrasound-Responsive Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Ultrasound-Responsive Drug Delivery Systems Sales by Country (2020-2031)

3.5.3 Europe Ultrasound-Responsive Drug Delivery Systems Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Ultrasound-Responsive Drug Delivery Systems Market Facts & Figures by Region

3.6.1 Asia Pacific Ultrasound-Responsive Drug Delivery Systems Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Ultrasound-Responsive Drug Delivery Systems Sales by Region (2020-2031)

3.6.3 Asia Pacific Ultrasound-Responsive Drug Delivery Systems Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Ultrasound-Responsive Drug Delivery Systems Market Facts & Figures by Country

3.7.1 Latin America Ultrasound-Responsive Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Ultrasound-Responsive Drug Delivery Systems Sales by Country (2020-2031)

3.7.3 Latin America Ultrasound-Responsive Drug Delivery Systems Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Ultrasound-Responsive Drug Delivery Systems Market Facts & Figures by Country

3.8.1 Middle East and Africa Ultrasound-Responsive Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Ultrasound-Responsive Drug Delivery Systems Sales by Country (2020-2031)

3.8.3 Middle East and Africa Ultrasound-Responsive Drug Delivery Systems Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Ultrasound-Responsive Drug Delivery Systems Sales by Type (2020-2031)

4.1.1 Global Ultrasound-Responsive Drug Delivery Systems Sales by Type (2020-2025)

4.1.2 Global Ultrasound-Responsive Drug Delivery Systems Sales by Type (2026-2031)

4.1.3 Global Ultrasound-Responsive Drug Delivery Systems Sales Market Share by Type (2020-2031)

4.2 Global Ultrasound-Responsive Drug Delivery Systems Revenue by Type (2020-2031)

4.2.1 Global Ultrasound-Responsive Drug Delivery Systems Revenue by Type (2020-2025)

4.2.2 Global Ultrasound-Responsive Drug Delivery Systems Revenue by Type (2026-2031)

4.2.3 Global Ultrasound-Responsive Drug Delivery Systems Revenue Market Share by Type (2020-2031)

4.3 Global Ultrasound-Responsive Drug Delivery Systems Price by Type (2020-2031)

5 Segment by Application

5.1 Global Ultrasound-Responsive Drug Delivery Systems Sales by Application (2020-2031)

5.1.1 Global Ultrasound-Responsive Drug Delivery Systems Sales by Application (2020-2025)

5.1.2 Global Ultrasound-Responsive Drug Delivery Systems Sales by Application (2026-2031)

5.1.3 Global Ultrasound-Responsive Drug Delivery Systems Sales Market Share by Application (2020-2031)

5.2 Global Ultrasound-Responsive Drug Delivery Systems Revenue by Application (2020-2031)

5.2.1 Global Ultrasound-Responsive Drug Delivery Systems Revenue by Application (2020-2025)

5.2.2 Global Ultrasound-Responsive Drug Delivery Systems Revenue by Application (2026-2031)

5.2.3 Global Ultrasound-Responsive Drug Delivery Systems Revenue Market Share by Application (2020-2031)

5.3 Global Ultrasound-Responsive Drug Delivery Systems Price by Application (2020-2031)

6 Key Companies Profiled

6.1 OxSonics

6.1.1 OxSonics Company Information

6.1.2 OxSonics Description and Business Overview

6.1.3 OxSonics Ultrasound-Responsive Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.1.4 OxSonics Ultrasound-Responsive Drug Delivery Systems Product Portfolio

6.1.5 OxSonics Recent Developments/Updates

6.2 Taiwan Liposome

6.2.1 Taiwan Liposome Company Information

6.2.2 Taiwan Liposome Description and Business Overview

6.2.3 Taiwan Liposome Ultrasound-Responsive Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Taiwan Liposome Ultrasound-Responsive Drug Delivery Systems Product Portfolio

6.2.5 Taiwan Liposome Recent Developments/Updates

6.3 PolyActiva

6.3.1 PolyActiva Company Information

6.3.2 PolyActiva Description and Business Overview

6.3.3 PolyActiva Ultrasound-Responsive Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.3.4 PolyActiva Ultrasound-Responsive Drug Delivery Systems Product Portfolio

6.3.5 PolyActiva Recent Developments/Updates

6.4 NanoCarrier

6.4.1 NanoCarrier Company Information

6.4.2 NanoCarrier Description and Business Overview

6.4.3 NanoCarrier Ultrasound-Responsive Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.4.4 NanoCarrier Ultrasound-Responsive Drug Delivery Systems Product Portfolio

6.4.5 NanoCarrier Recent Developments/Updates

6.5 Celsion

6.5.1 Celsion Company Information

6.5.2 Celsion Description and Business Overview

6.5.3 Celsion Ultrasound-Responsive Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Celsion Ultrasound-Responsive Drug Delivery Systems Product Portfolio

6.5.5 Celsion Recent Developments/Updates

6.6 Starpharma

6.6.1 Starpharma Company Information

6.6.2 Starpharma Description and Business Overview

6.6.3 Starpharma Ultrasound-Responsive Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Starpharma Ultrasound-Responsive Drug Delivery Systems Product Portfolio

6.6.5 Starpharma Recent Developments/Updates

6.7 InnoMedica

6.7.1 InnoMedica Company Information

6.7.2 InnoMedica Description and Business Overview

6.7.3 InnoMedica Ultrasound-Responsive Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.7.4 InnoMedica Ultrasound-Responsive Drug Delivery Systems Product Portfolio

6.7.5 InnoMedica Recent Developments/Updates

6.8 Insightec

6.8.1 Insightec Company Information

6.8.2 Insightec Description and Business Overview

6.8.3 Insightec Ultrasound-Responsive Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Insightec Ultrasound-Responsive Drug Delivery Systems Product Portfolio

6.8.5 Insightec Recent Developments/Updates

6.9 CarThera

6.9.1 CarThera Company Information

6.9.2 CarThera Description and Business Overview

6.9.3 CarThera Ultrasound-Responsive Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.9.4 CarThera Ultrasound-Responsive Drug Delivery Systems Product Portfolio

6.9.5 CarThera Recent Developments/Updates

6.10 Nanobiotix

6.10.1 Nanobiotix Company Information

6.10.2 Nanobiotix Description and Business Overview

6.10.3 Nanobiotix Ultrasound-Responsive Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Nanobiotix Ultrasound-Responsive Drug Delivery Systems Product Portfolio

6.10.5 Nanobiotix Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Ultrasound-Responsive Drug Delivery Systems Industry Chain Analysis

7.2 Ultrasound-Responsive Drug Delivery Systems Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Ultrasound-Responsive Drug Delivery Systems Production Mode & Process Analysis

7.4 Ultrasound-Responsive Drug Delivery Systems Sales and Marketing

7.4.1 Ultrasound-Responsive Drug Delivery Systems Sales Channels

7.4.2 Ultrasound-Responsive Drug Delivery Systems Distributors

7.5 Ultrasound-Responsive Drug Delivery Systems Customer Analysis

8 Ultrasound-Responsive Drug Delivery Systems Market Dynamics

8.1 Ultrasound-Responsive Drug Delivery Systems Industry Trends

8.2 Ultrasound-Responsive Drug Delivery Systems Market Drivers

8.3 Ultrasound-Responsive Drug Delivery Systems Market Challenges

8.4 Ultrasound-Responsive Drug Delivery Systems Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Ultrasound-Responsive Drug Delivery Systems Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Ultrasound-Responsive Drug Delivery Systems Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Ultrasound-Responsive Drug Delivery Systems Market Competitive Situation by Manufacturers in 2024

Table 4. Global Ultrasound-Responsive Drug Delivery Systems Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Ultrasound-Responsive Drug Delivery Systems Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Ultrasound-Responsive Drug Delivery Systems Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Ultrasound-Responsive Drug Delivery Systems Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Ultrasound-Responsive Drug Delivery Systems Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Ultrasound-Responsive Drug Delivery Systems, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Ultrasound-Responsive Drug Delivery Systems, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Ultrasound-Responsive Drug Delivery Systems, Product Type & Application

Table 12. Global Key Manufacturers of Ultrasound-Responsive Drug Delivery Systems, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Ultrasound-Responsive Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ultrasound-Responsive Drug Delivery Systems as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Ultrasound-Responsive Drug Delivery Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Ultrasound-Responsive Drug Delivery Systems Sales by Region (2020-2025) & (K Units)

Table 18. Global Ultrasound-Responsive Drug Delivery Systems Sales Market Share by Region (2020-2025)

Table 19. Global Ultrasound-Responsive Drug Delivery Systems Sales by Region (2026-2031) & (K Units)

Table 20. Global Ultrasound-Responsive Drug Delivery Systems Sales Market Share by Region (2026-2031)

Table 21. Global Ultrasound-Responsive Drug Delivery Systems Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Ultrasound-Responsive Drug Delivery Systems Revenue Market Share by Region (2020-2025)

Table 23. Global Ultrasound-Responsive Drug Delivery Systems Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Ultrasound-Responsive Drug Delivery Systems Revenue Market Share by Region (2026-2031)

Table 25. North America Ultrasound-Responsive Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Ultrasound-Responsive Drug Delivery Systems Sales by Country (2020-2025) & (K Units)

Table 27. North America Ultrasound-Responsive Drug Delivery Systems Sales by Country (2026-2031) & (K Units)

Table 28. North America Ultrasound-Responsive Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Ultrasound-Responsive Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Ultrasound-Responsive Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Ultrasound-Responsive Drug Delivery Systems Sales by Country (2020-2025) & (K Units)

Table 32. Europe Ultrasound-Responsive Drug Delivery Systems Sales by Country (2026-2031) & (K Units)

Table 33. Europe Ultrasound-Responsive Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Ultrasound-Responsive Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Ultrasound-Responsive Drug Delivery Systems Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Ultrasound-Responsive Drug Delivery Systems Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Ultrasound-Responsive Drug Delivery Systems Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Ultrasound-Responsive Drug Delivery Systems Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Ultrasound-Responsive Drug Delivery Systems Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Ultrasound-Responsive Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Ultrasound-Responsive Drug Delivery Systems Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Ultrasound-Responsive Drug Delivery Systems Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Ultrasound-Responsive Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Ultrasound-Responsive Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Ultrasound-Responsive Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Ultrasound-Responsive Drug Delivery Systems Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Ultrasound-Responsive Drug Delivery Systems Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Ultrasound-Responsive Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Ultrasound-Responsive Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Ultrasound-Responsive Drug Delivery Systems Sales (K Units) by Type (2020-2025)

Table 51. Global Ultrasound-Responsive Drug Delivery Systems Sales (K Units) by Type (2026-2031)

Table 52. Global Ultrasound-Responsive Drug Delivery Systems Sales Market Share by Type (2020-2025)

Table 53. Global Ultrasound-Responsive Drug Delivery Systems Sales Market Share by Type (2026-2031)

Table 54. Global Ultrasound-Responsive Drug Delivery Systems Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Ultrasound-Responsive Drug Delivery Systems Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Ultrasound-Responsive Drug Delivery Systems Revenue Market Share by Type (2020-2025)

Table 57. Global Ultrasound-Responsive Drug Delivery Systems Revenue Market Share by Type (2026-2031)

Table 58. Global Ultrasound-Responsive Drug Delivery Systems Price (US$/Unit) by Type (2020-2025)

Table 59. Global Ultrasound-Responsive Drug Delivery Systems Price (US$/Unit) by Type (2026-2031)

Table 60. Global Ultrasound-Responsive Drug Delivery Systems Sales (K Units) by Application (2020-2025)

Table 61. Global Ultrasound-Responsive Drug Delivery Systems Sales (K Units) by Application (2026-2031)

Table 62. Global Ultrasound-Responsive Drug Delivery Systems Sales Market Share by Application (2020-2025)

Table 63. Global Ultrasound-Responsive Drug Delivery Systems Sales Market Share by Application (2026-2031)

Table 64. Global Ultrasound-Responsive Drug Delivery Systems Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Ultrasound-Responsive Drug Delivery Systems Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Ultrasound-Responsive Drug Delivery Systems Revenue Market Share by Application (2020-2025)

Table 67. Global Ultrasound-Responsive Drug Delivery Systems Revenue Market Share by Application (2026-2031)

Table 68. Global Ultrasound-Responsive Drug Delivery Systems Price (US$/Unit) by Application (2020-2025)

Table 69. Global Ultrasound-Responsive Drug Delivery Systems Price (US$/Unit) by Application (2026-2031)

Table 70. OxSonics Company Information

Table 71. OxSonics Description and Business Overview

Table 72. OxSonics Ultrasound-Responsive Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. OxSonics Ultrasound-Responsive Drug Delivery Systems Product

Table 74. OxSonics Recent Developments/Updates

Table 75. Taiwan Liposome Company Information

Table 76. Taiwan Liposome Description and Business Overview

Table 77. Taiwan Liposome Ultrasound-Responsive Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Taiwan Liposome Ultrasound-Responsive Drug Delivery Systems Product

Table 79. Taiwan Liposome Recent Developments/Updates

Table 80. PolyActiva Company Information

Table 81. PolyActiva Description and Business Overview

Table 82. PolyActiva Ultrasound-Responsive Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. PolyActiva Ultrasound-Responsive Drug Delivery Systems Product

Table 84. PolyActiva Recent Developments/Updates

Table 85. NanoCarrier Company Information

Table 86. NanoCarrier Description and Business Overview

Table 87. NanoCarrier Ultrasound-Responsive Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. NanoCarrier Ultrasound-Responsive Drug Delivery Systems Product

Table 89. NanoCarrier Recent Developments/Updates

Table 90. Celsion Company Information

Table 91. Celsion Description and Business Overview

Table 92. Celsion Ultrasound-Responsive Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Celsion Ultrasound-Responsive Drug Delivery Systems Product

Table 94. Celsion Recent Developments/Updates

Table 95. Starpharma Company Information

Table 96. Starpharma Description and Business Overview

Table 97. Starpharma Ultrasound-Responsive Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Starpharma Ultrasound-Responsive Drug Delivery Systems Product

Table 99. Starpharma Recent Developments/Updates

Table 100. InnoMedica Company Information

Table 101. InnoMedica Description and Business Overview

Table 102. InnoMedica Ultrasound-Responsive Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. InnoMedica Ultrasound-Responsive Drug Delivery Systems Product

Table 104. InnoMedica Recent Developments/Updates

Table 105. Insightec Company Information

Table 106. Insightec Description and Business Overview

Table 107. Insightec Ultrasound-Responsive Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Insightec Ultrasound-Responsive Drug Delivery Systems Product

Table 109. Insightec Recent Developments/Updates

Table 110. CarThera Company Information

Table 111. CarThera Description and Business Overview

Table 112. CarThera Ultrasound-Responsive Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. CarThera Ultrasound-Responsive Drug Delivery Systems Product

Table 114. CarThera Recent Developments/Updates

Table 115. Nanobiotix Company Information

Table 116. Nanobiotix Description and Business Overview

Table 117. Nanobiotix Ultrasound-Responsive Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Nanobiotix Ultrasound-Responsive Drug Delivery Systems Product

Table 119. Nanobiotix Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Ultrasound-Responsive Drug Delivery Systems Distributors List

Table 123. Ultrasound-Responsive Drug Delivery Systems Customers List

Table 124. Ultrasound-Responsive Drug Delivery Systems Market Trends

Table 125. Ultrasound-Responsive Drug Delivery Systems Market Drivers

Table 126. Ultrasound-Responsive Drug Delivery Systems Market Challenges

Table 127. Ultrasound-Responsive Drug Delivery Systems Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Ultrasound-Responsive Drug Delivery Systems

Figure 2. Global Ultrasound-Responsive Drug Delivery Systems Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Ultrasound-Responsive Drug Delivery Systems Market Share by Type: 2024 & 2031

Figure 4. Microbubble-based Systems Product Picture

Figure 5. Nanobubble-based Systems Product Picture

Figure 6. Global Ultrasound-Responsive Drug Delivery Systems Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Ultrasound-Responsive Drug Delivery Systems Market Share by Application: 2024 & 2031

Figure 8. Pharmaceutical Companies

Figure 9. Healthcare Providers

Figure 10. Contract Manufacturing Organizations

Figure 11. Others

Figure 12. Global Ultrasound-Responsive Drug Delivery Systems Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Ultrasound-Responsive Drug Delivery Systems Market Size (2020-2031) & (US$ Million)

Figure 14. Global Ultrasound-Responsive Drug Delivery Systems Sales (2020-2031) & (K Units)

Figure 15. Global Ultrasound-Responsive Drug Delivery Systems Average Price (US$/Unit) & (2020-2031)

Figure 16. Ultrasound-Responsive Drug Delivery Systems Report Years Considered

Figure 17. Ultrasound-Responsive Drug Delivery Systems Sales Share by Manufacturers in 2024

Figure 18. Global Ultrasound-Responsive Drug Delivery Systems Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Ultrasound-Responsive Drug Delivery Systems Players: Market Share by Revenue in Ultrasound-Responsive Drug Delivery Systems in 2024

Figure 20. Ultrasound-Responsive Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Ultrasound-Responsive Drug Delivery Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Ultrasound-Responsive Drug Delivery Systems Sales Market Share by Country (2020-2031)

Figure 23. North America Ultrasound-Responsive Drug Delivery Systems Revenue Market Share by Country (2020-2031)

Figure 24. United States Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Ultrasound-Responsive Drug Delivery Systems Sales Market Share by Country (2020-2031)

Figure 27. Europe Ultrasound-Responsive Drug Delivery Systems Revenue Market Share by Country (2020-2031)

Figure 28. Germany Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Ultrasound-Responsive Drug Delivery Systems Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Ultrasound-Responsive Drug Delivery Systems Revenue Market Share by Region (2020-2031)

Figure 35. China Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Ultrasound-Responsive Drug Delivery Systems Sales Market Share by Country (2020-2031)

Figure 43. Latin America Ultrasound-Responsive Drug Delivery Systems Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Ultrasound-Responsive Drug Delivery Systems Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Ultrasound-Responsive Drug Delivery Systems Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Ultrasound-Responsive Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Ultrasound-Responsive Drug Delivery Systems by Type (2020-2031)

Figure 54. Global Revenue Market Share of Ultrasound-Responsive Drug Delivery Systems by Type (2020-2031)

Figure 55. Global Ultrasound-Responsive Drug Delivery Systems Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Ultrasound-Responsive Drug Delivery Systems by Application (2020-2031)

Figure 57. Global Revenue Market Share of Ultrasound-Responsive Drug Delivery Systems by Application (2020-2031)

Figure 58. Global Ultrasound-Responsive Drug Delivery Systems Price (US$/Unit) by Application (2020-2031)

Figure 59. Ultrasound-Responsive Drug Delivery Systems Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions